High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) ...

Recent years have witnessed extraordinary progress in tissue repair, driven primarily by innovations in biomaterial design and biofabrication. In ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and safety profile of ...

This meeting will serve as a kick-off for the National Academies consensus study Biotechnology Capabilities for National Security Needs--Leveraging Advances in Transdisciplinary Biotechnology. This me ...

Cyanophycin is a versatile nitrogen storage polymer naturally synthesised by many bacteria. Composed of a poly-L-aspartate backbone with covalently attached L-arginine residues, this biopolymer ...

China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should invest ...